RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marian Melish to Mucocutaneous Lymph Node Syndrome

This is a "connection" page, showing publications Marian Melish has written about Mucocutaneous Lymph Node Syndrome.
  1. Bratincsak A, Limm-Chan BN, Nerurkar VR, Ching LL, Reddy VD, Lim E, Shohet RV, Melish ME. Study design and rationale to assess Doxycycline Efficacy in preventing coronary Artery Lesions in children with Kawasaki disease (DEAL trial) - A phase II clinical trial. Contemp Clin Trials. 2018 02; 65:33-38.
    View in: PubMed
    Score: 0.613
  2. Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, Forbes S, Schonberger LB, Melish M. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J. 2010 Aug; 69(8):194-7.
    View in: PubMed
    Score: 0.368
  3. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005 May; 146(5):662-7.
    View in: PubMed
    Score: 0.256
  4. Holman RC, Curns AT, Belay ED, Steiner CA, Effler PV, Yorita KL, Miyamura J, Forbes S, Schonberger LB, Melish M. Kawasaki syndrome in Hawaii. Pediatr Infect Dis J. 2005 May; 24(5):429-33.
    View in: PubMed
    Score: 0.256
  5. Burney JA, DeHaan LL, Shimizu C, Bainto EV, Newburger JW, DeBiasi RL, Dominguez SR, Portman MA, Melish M, Bratincsak A, Fabi M, Corinaldesi E, Yu JJ, Gee P, Kitano N, Tremoulet AH, Cayan DR, Burns JC. Temporal clustering of Kawasaki disease cases around the world. Sci Rep. 2021 11 19; 11(1):22584.
    View in: PubMed
    Score: 0.202
  6. Dawson TJ, Vuong CT, Ma SCY, Russell CR, Melish ME, Bratincsak A. Mapping the Trends of Kawasaki Disease in Hawai'i from 1996 to 2018. Hawaii J Health Soc Welf. 2020 05 01; 79(5 Suppl 1):104-111.
    View in: PubMed
    Score: 0.181
  7. Ma S, Choi SY, Ahn HJ, Siu AM, Melish ME, Bratincsak A. The Importance of Echocardiogram during the Second Week of Illness in Children with Kawasaki Disease. J Pediatr. 2020 03; 218:72-77.e1.
    View in: PubMed
    Score: 0.176
  8. Garnett GM, Kimball S, Melish ME, Thompson KS, Puapong DP, Johnson SM, Woo RK. Appendicitis as the presenting manifestation of Kawasaki disease. Pediatr Surg Int. 2014 May; 30(5):549-52.
    View in: PubMed
    Score: 0.116
  9. Rod? X, Ballester J, Cayan D, Melish ME, Nakamura Y, Uehara R, Burns JC. Association of Kawasaki disease with tropospheric wind patterns. Sci Rep. 2011; 1:152.
    View in: PubMed
    Score: 0.101
  10. Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, Melish ME, Jackson MA, Asmar BI, Lang DJ, Connor JD, Capparelli EV, Keen ML, Mamun K, Keenan GF, Ramilo O. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2008 Dec; 153(6):833-8.
    View in: PubMed
    Score: 0.080
  11. Chua PK, Melish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol. 2003 Mar; 10(2):308-14.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support